Ray Dalio’s Select Medical SEM Stock Holding History

Ray Dalio’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-65,173	Closed	-$968K	–	1196
2025 Q4	$968K	Buy	65,173 +24,021	+58%	+$340K	﹤0.01%	895
2025 Q3	$528K	Buy	+41,152	New	+$548K	﹤0.01%	920

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ray Dalio's SEM Position: Q1 2026 in Review

Ray Dalio sold out of Select Medical (SEM) in Q1 2026, closing a stake of 65,173 shares — an estimated $968K sold.

Ray Dalio first reported a position in SEM in Q3 2025 and held it in 2 quarters. The position peaked at $968K in Q4 2025. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

Ray Dalio reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
Ray Dalio sold 65,173 Select Medical shares in Q1 2026, an estimated $968K.
Ray Dalio first reported a position in Select Medical in Q3 2025 and held it in 2 quarters.
Ray Dalio's Select Medical position peaked at $968K in Q4 2025.
277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.